Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Feldman

Showing results (1301-1310 of 1,619) with videos related to

Pageof 162
Sort By:
The British Journal of Dermatology|September 27, 2003
Development and validation of a health-related quality of life instrument for women with melasmaR Balkrishnan, A J McMichael, F T Camacho, et al.
Archives of Dermatology|March 17, 2010
Incidence estimate of nonmelanoma skin cancer in the United States, 2006Howard W Rogers, Martin A Weinstock, Ashlynne R Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysisRussell A Moore, Nelly Adel, Elyn Riedel, et al.
Cutis|August 24, 2018
Screening for depression in rosacea patientsHossein Alinia, Leah A Cardwell, Sara M Tuchayi, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 4, 2004
Why are there differences in the perceived safety of office-based surgery?John G Hancox, Arun P Venkat, Alicia Hill, et al.
Dermatology Online Journal|September 7, 2004
Tacrolimus ointment: utilization patterns in children under age 2 yearsTamara Salam Housman, Amy B Norton, Steven R Feldman, et al.
The British Journal of Dermatology|July 17, 2008
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasisS R Feldman, A B Gottlieb, M Bala, et al.
Investigational New Drugs|June 27, 2022
A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumorsNabil Adra, David J Vaughn, Lawrence H Einhorn, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2021
A Comparison of Alternative Medicine Users and Non-Users in Patients With Hidradenitis SuppurativaJordan Lane, Veronica Emmerich, Aditi Senthilnathan, et al.
Cutis|October 6, 2010
Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trialBrad A Yentzer, Rachel A Ade, Julie M Fountain, et al.
Pageof 162

Showing results (1301-1310 of 1,619) with videos related to

Sort By:
Pageof 162
The British Journal of Dermatology|September 27, 2003
Development and validation of a health-related quality of life instrument for women with melasmaR Balkrishnan, A J McMichael, F T Camacho, et al.
Archives of Dermatology|March 17, 2010
Incidence estimate of nonmelanoma skin cancer in the United States, 2006Howard W Rogers, Martin A Weinstock, Ashlynne R Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysisRussell A Moore, Nelly Adel, Elyn Riedel, et al.
Cutis|August 24, 2018
Screening for depression in rosacea patientsHossein Alinia, Leah A Cardwell, Sara M Tuchayi, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 4, 2004
Why are there differences in the perceived safety of office-based surgery?John G Hancox, Arun P Venkat, Alicia Hill, et al.
Dermatology Online Journal|September 7, 2004
Tacrolimus ointment: utilization patterns in children under age 2 yearsTamara Salam Housman, Amy B Norton, Steven R Feldman, et al.
The British Journal of Dermatology|July 17, 2008
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasisS R Feldman, A B Gottlieb, M Bala, et al.
Investigational New Drugs|June 27, 2022
A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumorsNabil Adra, David J Vaughn, Lawrence H Einhorn, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2021
A Comparison of Alternative Medicine Users and Non-Users in Patients With Hidradenitis SuppurativaJordan Lane, Veronica Emmerich, Aditi Senthilnathan, et al.
Cutis|October 6, 2010
Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trialBrad A Yentzer, Rachel A Ade, Julie M Fountain, et al.
Pageof 162